Loading...
Bortezomib — Export Intelligence Report
2025-Q4 · TransData Nexus
PHARMA TRADE INTELLIGENCE
INDIA EXPORT INTELLIGENCE REPORT
Bortezomib
2025-Q4
Comprehensive analysis of India’s bortezomib export trade — suppliers, buyers, prices, routes, and every shipment record.
89
Shipments
$1.09M
Trade Value
41
Suppliers
36
Buyers
39
Countries
Scan for online report
Talk to our analyst: +91 95950 78788
https://transdatanexus.com/pharmaceutical/bortezomib
01
PART I — OVERVIEW
Executive Summary
At-a-glance KPIs, key findings, and strategic positioning of India’s bortezomib trade — 2025-Q4
KEY TAKEAWAY
Bortezomib 2025-Q4 exports total $1.1M across 39 countries, with SUN PHARMACEUTICAL INDUSTRIES LTD commanding 61.6% market share.
TOTAL SHIPMENTS
89
2025-Q4
EXPORT VALUE
$1.1M
FOB USD
TOTAL QUANTITY
111.8K
units shipped
INDIAN SUPPLIERS
41
unique exporters
GLOBAL BUYERS
36
unique importers
DESTINATIONS
39
countries
MEDIAN UNIT PRICE
$7.60
per unit
TOP-5 SHARE
90.8%
of total USD
BRANDED SHARE
67.4%
60 shipments
DOSAGE FORMS
5
product types
6 KEY FINDINGS
1
SUN PHARMACEUTICAL INDUSTRIES LTD is India's #1 Bortezomib exporter with $673.6K (61.6% market share).→ §5, Indian Supplier Rankings
2
Bortezomib reached 39 countries, with Belgium as the top destination ($522.7K).→ §4, Global Destination Map
3
Market concentration is high (HHI: 4059) — top 10 suppliers control 96.6% of exports.→ §5, Indian Supplier Rankings
4
88.9% of buyers (32 of 36) source from a single Indian supplier — potential poaching opportunities.→ §6, Global Buyer Rankings
5
Injection dominates (87.1%) across 5 dosage forms.→ §7, Price Benchmarks
6
38 countries have ≤5 Indian suppliers — easy-entry markets for SME exporters.→ §9, Strategic Opportunities
WHO THIS REPORT IS FOR
S SUPPLIERS (Indian pharma exporters)
- See which buyers your competitors are shipping to, at what price, through which ports
- Identify buyers that are single-sourced (poaching opportunities)
- Benchmark your pricing and catalog vs the Top 25
B BUYERS (global importers)
- Discover which Indian exporters supply this product and what they sell
- Benchmark the price you are paying vs the market median by country and dosage
- Identify alternative suppliers with proven exports to similar destinations
Figure 1.1 SUN PHARMACEUTICAL INDUSTRIES LTD leads in volume — how do 30 exporters compare on price × volume?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Every bubble is one Indian bortezomib exporter. X-axis = shipment count; Y-axis = average unit price; bubble size = total revenue. Dashed lines split at the median — exporters in the top-right (Bulk Leaders) combine high volume with premium pricing.
HOW TO READ THIS REPORT
60 seconds
Scan this page — KPIs, thesis, flagship chart, top findings
5 minutes
Read every Key Takeaway line across §1–§9
30 minutes
Read sections tagged for your role ([S] or [B]) end-to-end
In depth
Drill into §10 for your country · supplier / buyer directories at end
02
PART I — OVERVIEW
About This Report
Data sources, methodology, trust signals, and what this Bortezomib report covers
KEY TAKEAWAY
Every figure in this report is grounded in real commercial bortezomib trade records. Data comes from official customs filings and public trade sources, runs through a multi-layer quality process, and lands in a clean, consistent report you can rely on.
S FOR SUPPLIERS
Every competitor benchmark, market share figure, and buyer list in this report comes from verified commercial shipments — not surveys or estimates. Use them with confidence when planning your next pitch.
B FOR BUYERS
Every supplier profile, price benchmark, and trade route in this report reflects what that supplier actually ships — real volumes, real destinations, real prices. Use them to qualify and compare Indian bortezomib suppliers.
§2.1 Reporting parameters · the scope of this 2025-Q4 Bortezomib India trade report
Product scope
Bortezomib
All variants merged — branded and generic formulations of bortezomib
Time period
2025-Q4
October, November, December 2025 — a single-quarter snapshot
Data sources
Official & public trade records
Government customs filings, public trade databases and licensed commercial feeds
Geography
India origin → global
Indian sea and air ports shipping to destination markets worldwide
Currency
USD (FOB)
Declared Free-on-Board value at the Indian port of loading
Shipments analysed
89
Every commercial bortezomib trade record in the period, aggregated and deduplicated
§2.2 Our quality process · Figure 2.1
Figure 2.1 From raw trade records to a clean report — the four quality pillars.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Raw trade data (left) flows through four quality checks — source verification, format standardisation, entity matching, and deduplication — to produce the clean, reliable data (right) behind every chart and table in this report.
§2.3 Trust signals · what you can rely on in the numbers you read
DATA COVERAGE
10M+
Pharmaceutical trade records across the full TransData Nexus platform.
COUNTRIES
150+
Origin and destination countries covered in the global pharma trade database.
DATA ACCURACY
99.9%
Validation rate on core fields — supplier, buyer, product, quantity, value.
UPDATE FREQUENCY
Daily
Platform refresh cadence. This report is a snapshot from the same live data.
§2.4 Limitations · what the data does and does not tell you
WHAT THIS DATA DOES AND DOES NOT SAY
- Prices are at the Indian port of loading (FOB), not the final delivered cost in the destination country. Freight, insurance, import duty and local margin are not included.
- This is a single-quarter snapshot. Multi-quarter trends, year-over-year growth and historical comparisons are available on the full platform.
- A small number of records have incomplete transport mode or destination port fields; these appear blank in the shipment register but are still counted in totals.
- This report is a commercial intelligence tool, not a legal audit. For high-stakes decisions, cross-reference with the underlying trade records via the full platform.
03
PART II — MARKET STRUCTURE
Quarterly Trade Overview
Monthly trends, regional performance, and ranking shifts — 2025-Q4
KEY TAKEAWAY
2025-Q4 followed a mixed: Oct $214.7K, Nov $744.8K, Dec $133.9K. Shipment counts rose across the quarter.
S FOR SUPPLIERS
Track which months your competitors were most active, which destinations rose or fell, and whether the Nov dip hit your segment. The bump charts show rank movement — watch for rivals climbing past you.
B FOR BUYERS
Identify whether your current Indian supplier maintained steady shipments through the quarter, or whether they pulled back. Steady suppliers during dips signal reliable partnerships.
1
$214.7K
Oct USD
10 shipments
2
$744.8K
Nov USD
+246.9% MoM
3
$133.9K
Dec USD
-82.0% MoM
4
Mixed
Q4 growth shape
Oct → Nov → Dec
Fig 3.1 Nov rose 246.9% in USD but shipment count kept climbing.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Blue bars = monthly USD. Orange line = shipment count. When bars drop but line rises, average shipment value fell. Insight: Oct opened at $215K, making it the middle month by value.
Fig 3.2 Q4 cumulative USD reached $1.1M.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: The curve shows the running total across the quarter. A steeper slope means that month contributed more revenue. Insight: The curve’s steepest section reveals which month drove the most trade value.
Fig 3.3 $530K rise in Nov, $611K decline in Dec.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Blue bars = absolute monthly value. Red = month-over-month loss; green = gain. Insight: Trade grew steadily across the quarter.
Fig 3.4 Regional breakdown by month — which corridors swung most?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each coloured layer is one destination region. Layer height = USD in that month. Insight: The top region contributed the most, while the smallest region had the least volume.
§3.1 Monthly summary
| Oct | $215K | 10 shipments |
| Nov | $745K | 35 shipments |
| Dec | $134K | 44 shipments |
| Q4 Total | $1.1M | 89 shipments |
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
Fig 3.5 Top 10 destination countries by monthly USD rank — who’s rising?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each line traces a country’s monthly rank. Lines crossing = rank swaps. Insight: Brazil held #1 throughout the quarter.
Fig 3.6 Top 10 Indian exporters by monthly USD rank.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each line traces a supplier’s monthly rank. Flat = stable position; crossing = rank change. Insight: SUN PHARMACEUTICAL INDUSTRIES LTD maintained its leading position.
04
PART II — MARKET STRUCTURE
Global Destination Map
Which countries import bortezomib from India, how much they buy, and who supplies each market
KEY TAKEAWAY
Belgium absorbs 47.8% of India’s 2025-Q4 bortezomib trade ($522.7K). Beyond the top 10 destinations, 38 countries have fewer than 5 Indian suppliers each — white-space markets where new entrants face minimal competition. Africa has 16 destination countries, the widest regional diversity.
S FOR SUPPLIERS
Use the flow map and lanes table to see which destinations your competitors dominate. For small and mid-size suppliers: look beyond the leading markets — the 38 countries in the long tail have fewer than 5 Indian suppliers each and low competitive barriers.
B FOR BUYERS
Find your country on the map to see how much bortezomib India ships to your market, who the top suppliers are, and whether you’re in a concentrated or competitive corridor.
Asia
$254K
23.3% of trade
11 countries · 26 shipments
Europe
$568K
52.0% of trade
4 countries · 15 shipments
Americas
$226K
20.6% of trade
7 countries · 19 shipments
Africa
$44K
4.1% of trade
16 countries · 28 shipments
Oceania
$449
0.0% of trade
1 countries · 1 shipments
Fig 4.1 Belgium is the #1 corridor ($523K) — 30 flow arcs from India radiate across 5 continents.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: The world map shows every country colored by how much Indian bortezomib it receives (light = low, dark = high). Orange arcs radiate from India to the top 30 destinations; arc thickness = USD value. All destinations are labeled with country name + USD.
§4.1 Top 10 bilateral trade lanes (India → destination) with top Indian suppliers
| # | Destination | Total USD | Ships | #1 Indian supplier | USD | #2 Indian supplier | USD | #3 Indian supplier | USD |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Belgium | $523K | 5 | SUN PHARMACEUTICAL INDUSTRIES LTD | $523K | — | — | — | — |
| 2 | Brazil | $151K | 6 | SUN PHARMACEUTICAL INDUSTRIES LTD | $151K | — | — | — | — |
| 3 | Israel | $131K | 2 | MSN LABORATORIES PVT LTD | $131K | — | — | — | — |
| 4 | Thailand | $73K | 1 | MYLAN LABORATORIES LTD | $73K | — | — | — | — |
| 5 | Germany | $41K | 3 | FRESENIUS KABI ONCOLOGY LTD | $41K | — | — | — | — |
| 6 | Chile | $35K | 2 | FRESENIUS KABI ONCOLOGY LTD | $33K | MSN LABORATORIES PVT LTD | $2K | — | — |
| 7 | Afghanistan | $33K | 9 | SAMARTH LIFE SCIENCES PVT LTD | $21K | KWALITY PHARMACEUTICALS LTD | $5K | KERK | $4K |
| 8 | Dominican Republic | $30K | 2 | GETWELL PHARMA INDIA PVT LTD | $30K | — | — | — | — |
| 9 | Lesotho | $11K | 2 | BRUCK PHARMA PVT LTD | $11K | — | — | — | — |
| 10 | South Africa | $11K | 1 | GLENMARK PHARMACEUTICALS LTD | $11K | — | — | — | — |
Table 4.1 — Top 10 destination countries ranked by trade value, with the largest Indian suppliers for each market.
Fig 4.2 Asia leads at 23.3% of USD — but Belgium is the single largest market.
Region → country treemap
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Column width = region USD share. Within each column, cells are stacked by country, height = share within region.
§4.2 Destination concentration
47.8%
#1 country share
Belgium alone
84.1%
Top 5 share
5 of 39 countries
98.0%
Top 15 share
Long tail of 24 countries = 2.0%
HHI 2711
Destination HHI
Highly concentrated
39
Countries served
Global pharma reach from India
16
Africa countries
Widest regional diversity
Source: TransData Nexus trade data platform
05
PART III — WHO’S IN THIS MARKET
Indian Supplier Rankings & Profiles
41 Indian exporters ranked by value — profiles, portfolios, and competitive intelligence
KEY TAKEAWAY
SUN PHARMACEUTICAL INDUSTRIES LTD ($673.6K, 61.6% share) and MSN LABORATORIES PVT LTD ($133.4K) together control 73.8% of India’s 2025-Q4 bortezomib trade. The top 5 suppliers hold 90.8%. 41 companies shipped at least once.
S FOR SUPPLIERS
Find your rank, your competitors’ ranks, and the gap in USD/share between you. The profile pages show each top supplier’s buyer portfolio, dosage mix and route map — your competitive-intelligence toolkit.
B FOR BUYERS
Find potential Indian bortezomib suppliers ranked by size, catalog breadth and destination reach. The profile pages reveal which suppliers have proven trade lanes to your region.
Fig 5.1 SUN PHARMACEUTICAL INDUSTRIES LTD leads by $540K over MSN LABORATORIES PVT LTD — top 20 Indian exporters ranked by trade value
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one Indian supplier ranked by USD. The (#N) shows their rank by shipment count — mismatches reveal pricing strategy. Insight: J S LABS is #18 by value but #5 by volume.
Fig 5.2 SUN PHARMACEUTICAL INDUSTRIES LTD also leads by shipment count (11) but ranking shifts for volume-heavy players
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Same suppliers re-ranked by shipment count. The (#N) shows their rank by USD value. Insight: J S LABS moves from #5 by volume to #18 by value — fewer but higher-value shipments.
05
PART III — WHO’S IN THIS MARKET
Supply Landscape — Archetypes & Concentration
How India’s 41 bortezomib suppliers split into strategic segments
KEY TAKEAWAY
11 suppliers (25%) generate 97.1% of total trade value. The market splits into four archetypes: Market Leaders, High-Value specialists, Volume players, and a long tail.
Fig 5.3 SUN PHARMACEUTICAL INDUSTRIES LTD and MSN LABORATORIES PVT LTD sit in the leaders zone — high volume AND high value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bubble is one Indian supplier. X-axis = shipment count (log scale); Y-axis = total USD value (log scale); bubble size = revenue. Blue dashed lines split at the median. Market Leaders (top-right) combine high volume with high value. Premium Niche (top-left) ship fewer but higher-value consignments. Volume Players (bottom-right) compete on quantity. Long-Tail (bottom-left) are small or occasional exporters. Conclusion: the log scale reveals clear strategic clusters — use this map to identify where your company sits relative to competitors.
Fig 5.4 25% of suppliers = 97.1% of USD — classic concentration.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Top bar = supplier %, bottom bar = USD %. The gap = market concentration.
Product variety — how many formulations each supplier ships
| # | Supplier | Dosage forms | Countries | USD |
|---|---|---|---|---|
| 1 | MYGENIC HEALTHCARE PVT LTD | 3 | 1 | $8K |
| 2 | MSN LABORATORIES PVT LTD | 2 | 2 | $133K |
| 3 | SUN PHARMACEUTICAL INDUSTRIES LTD | 1 | 2 | $674K |
| 4 | FRESENIUS KABI ONCOLOGY LTD | 1 | 4 | $77K |
| 5 | MYLAN LABORATORIES LTD | 1 | 1 | $73K |
| 6 | GETWELL PHARMA INDIA PVT LTD | 1 | 3 | $35K |
| 7 | SAMARTH LIFE SCIENCES PVT LTD | 1 | 1 | $21K |
| 8 | BRUCK PHARMA PVT LTD | 1 | 3 | $15K |
| 9 | GLENMARK PHARMACEUTICALS LTD | 1 | 1 | $11K |
| 10 | THERDOSE PHARMA PVT LTD | 1 | 1 | $8K |
Table 5.1 — The more dosage forms a supplier ships, the more versatile their manufacturing capability.
05
PART III — WHO’S IN THIS MARKET
Supply Landscape — India Origin Geography & Concentration
Which Indian cities and states are the bortezomib manufacturing hubs
KEY TAKEAWAY
Mumbai and Andheri Kurla Road together account for $675K of India’s 2025-Q4 bortezomib trade.
Fig 5.5 Mumbai (8 exporters, $412K) and Andheri Kurla Road (1 exporters, $263K) are India’s bortezomib capitals.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Orange bubbles mark major pharma hub cities; bubble size = USD value. Every hub labeled.
§5.1 Supplier concentration metrics
90.8%
Top 5 share
5 of 41 suppliers
96.6%
Top 10 share
10 of 41 suppliers
97.1%
Top 25% share
11 suppliers = 97% USD
HHI 4059
Supplier HHI
Concentrated
41
Total suppliers
shipped Bortezomib in 2025-Q4
20+ cities
Indian hubs
Mumbai and Andheri Kurla Road lead
§5.2 Coming next: 3 exporter deep-dive profiles
Each of the top 3 suppliers gets a dedicated 2-page profile with:
- 6 KPI cards — trade value, shipments, countries, buyers, avg ship value, branded share
- Dosage form breakdown — what formulations they ship
- Monthly trend — Oct / Nov / Dec trajectory
- Trade flow map — supplier → country → importer connections
- Buyer portfolio with lock-in analysis
SUPPLIER PROFILES IN THIS REPORT
| #1 | SUN PHARMACEUTICAL INDUSTRIES LTD | $674K |
| #2 | FRESENIUS KABI ONCOLOGY LTD | $77K |
| #3 | GETWELL PHARMA INDIA PVT LTD | $35K |
#1
EXPORTER PROFILE #1 OF 3
SUN PHARMACEUTICAL INDUSTRIES LTD
Mumbai · India’s #1 bortezomib supplier by USD · 2025-Q4
2025-Q4 USD
$674K
61.6% market share
SHIPMENTS
11
avg $61K/ship
COUNTRIES
2
destination markets
BUYERS
4
3 single-sourced
BRANDED
82%
of shipments
DOSAGE FORMS
1
product types
TOP 2 DESTINATIONS
Belgium is the #1 market at $523K (78% of trade), followed by Brazil at $151K. 2 countries served.
| # | Country | USD | Ships | Share |
|---|---|---|---|---|
| 1 | Belgium | $523K | 5 | 77.6% |
| 2 | Brazil | $151K | 6 | 22.4% |
MONTHLY TREND
Nov peaked at $608K. Oct was the weakest at $0.
PRODUCT MIX
Injection dominates at 100% of trade.
TOP BUYERS · 3/3 LOCKED IN
3 of 3 buyers source exclusively from this supplier — high lock-in with low competitive threat.
| Buyer | Country | USD | Status |
|---|---|---|---|
| YUSEN LOGISTICS BENELU… | Belgium | $275K | ⚠ Locked |
| Undisclosed buyer | Brazil | $263K | N/A |
| SUN FARMACEUTICA DO BR… | Brazil | $126K | ⚠ Locked |
| SUN FARMACUTICA DO BRA… | Brazil | $10K | ⚠ Locked |
#1
EXPORTER PROFILE #1 OF 3 — TRADE FLOW MAP
SUN PHARMACEUTICAL INDUSTRIES LTD — Supplier → Country → Importer
2 destination countries, top 5 importers per country
Fig 5.P1.3 Belgium absorbs $523K — the thickest ribbon.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 2 destinations and up to 3 importers per destination.
#3
EXPORTER PROFILE #2 OF 3
FRESENIUS KABI ONCOLOGY LTD
New Delhi · India’s #3 bortezomib supplier by USD · 2025-Q4
2025-Q4 USD
$77K
7.1% market share
SHIPMENTS
7
avg $11K/ship
COUNTRIES
4
destination markets
BUYERS
5
4 single-sourced
BRANDED
57%
of shipments
DOSAGE FORMS
1
product types
TOP 4 DESTINATIONS
Germany is the #1 market at $41K (53% of trade), followed by Chile at $33K. 4 countries served.
| # | Country | USD | Ships | Share |
|---|---|---|---|---|
| 1 | Germany | $41K | 3 | 53.1% |
| 2 | Chile | $33K | 1 | 43.0% |
| 3 | Hungary | $3K | 2 | 3.4% |
| 4 | Costa Rica | $401 | 1 | 0.5% |
MONTHLY TREND
Dec was the strongest month, ending the quarter on a high at $41K.
PRODUCT MIX
Injection dominates at 100% of trade.
TOP BUYERS · 4/4 LOCKED IN
4 of 4 buyers source exclusively from this supplier — high lock-in with low competitive threat.
| Buyer | Country | USD | Status |
|---|---|---|---|
| FRESENIUS KABI DEUTSCH… | Germany | $41K | ⚠ Locked |
| FRESENIUS KABI CHILE L… | Chile | $33K | ⚠ Locked |
| EUROFINS BIOPHARMA PRO… | Hungary | $1K | ⚠ Locked |
| Undisclosed buyer | Hungary | $1K | N/A |
| BIO TECH PHARMA S.A | Costa Rica | $401 | ⚠ Locked |
#3
EXPORTER PROFILE #2 OF 3 — TRADE FLOW MAP
FRESENIUS KABI ONCOLOGY LTD — Supplier → Country → Importer
4 destination countries, top 5 importers per country
Fig 5.P2.3 Germany absorbs $41K — the thickest ribbon.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 4 destinations and up to 2 importers per destination.
#5
EXPORTER PROFILE #3 OF 3
GETWELL PHARMA INDIA PVT LTD
Gurgaon · India’s #5 bortezomib supplier by USD · 2025-Q4
2025-Q4 USD
$35K
3.2% market share
SHIPMENTS
5
avg $7K/ship
COUNTRIES
3
destination markets
BUYERS
4
3 single-sourced
BRANDED
80%
of shipments
DOSAGE FORMS
1
product types
TOP 3 DESTINATIONS
Dominican Republic is the #1 market at $30K (85% of trade), followed by Madagascar at $3K. 3 countries served.
| # | Country | USD | Ships | Share |
|---|---|---|---|---|
| 1 | Dominican Republic | $30K | 2 | 85.4% |
| 2 | Madagascar | $3K | 2 | 8.7% |
| 3 | Kenya | $2K | 1 | 5.9% |
MONTHLY TREND
Nov peaked at $35K. Oct was the weakest at $0.
PRODUCT MIX
Injection dominates at 100% of trade.
TOP BUYERS · 3/3 LOCKED IN
3 of 3 buyers source exclusively from this supplier — high lock-in with low competitive threat.
| Buyer | Country | USD | Status |
|---|---|---|---|
| PZAC CORP | Dominican Republic | $15K | ⚠ Locked |
| Undisclosed buyer | Dominican Republic | $15K | N/A |
| CENTRALE DACHATS DE ME… | Madagascar | $3K | ⚠ Locked |
| NAIROBI ENTERPRISES LTD | Kenya | $2K | ⚠ Locked |
#5
EXPORTER PROFILE #3 OF 3 — TRADE FLOW MAP
GETWELL PHARMA INDIA PVT LTD — Supplier → Country → Importer
3 destination countries, top 5 importers per country
Fig 5.P3.3 Dominican Republic absorbs $30K — the thickest ribbon.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 3 destinations and up to 2 importers per destination.
06
PART III — WHO’S IN THIS MARKET
Global Buyer Rankings & Intelligence
36 importers across 39 countries — who is buying Indian bortezomib and how much
KEY TAKEAWAY
The demand side is dramatically more fragmented than supply: the top 25 importers together hold only 70.1% of total USD. 89% of buyers source from a single Indian supplier — a vast pool of lock-in candidates.
S FOR SUPPLIERS
Find the importers buying from your competitors. The rankings reveal who has volume, who pays well, and who sources from multiple Indian suppliers (potential pitch targets).
B FOR BUYERS
See where you rank among global importers of Indian bortezomib. Compare your USD and shipment count against peers in your country and dosage segment.
Fig 6.1 YUSEN LOGISTICS BENELUX BELGIUM is the #1 importer at $275K (25.2%) — top 25 by trade value
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one global importer ranked by USD.
Fig 6.2 Re-ranked by shipment count — compare with Fig 6.1 for divergences
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Same 25 importers re-ranked by shipment count.
§6.1 Sourcing diversity — how many Indian suppliers does each buyer use?
89%
Single-source
32 buyers rely on exactly 1 Indian supplier
6%
Dual-source
2 buyers use 2 Indian suppliers
0%
Multi-source (3–4)
0 buyers diversified across 3–4
6%
Broad-source (5+)
2 buyers with 5+ Indian suppliers
06
PART III — WHO’S IN THIS MARKET
Single-Source Buyers & Price Benchmark
Lock-in opportunities grouped by country + where each buyer sits on the price spectrum
KEY TAKEAWAY
These importers source bortezomib from exactly one Indian supplier. For each one, the table shows the incumbent, price, and dosage.
S FOR SUPPLIERS
This is your target list. Each row is a buyer locked into one competitor. Offer 5–10% better pricing to win the second-source slot.
B FOR BUYERS
If you see your company here, you are fully dependent on one Indian supplier. Consider qualifying a second source.
§6.2 Single-source lock-in by country
Afghanistan 4 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| MUBARAK HASHIMI LTD | KERK | $4K | $3.345 | Injection |
| ETEMED MOSLEH LTD | RESCUERS LIFE SCIENC… | $2K | $3.500 | Injection |
| GULF IMPEX FZC | MEDMATRIX ASSOCIATES | $306.146 | $6.123 | Injection |
| SARTAJ ENTERPRISES LTD | SARTAJ PHARMA PVT LTD | $31.321 | $0.031 | Injection |
Brazil 2 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| SUN FARMACEUTICA DO BR… | SUN PHARMACEUTICAL I… | $126K | $4.652 | Injection |
| SUN FARMACUTICA DO BRA… | SUN PHARMACEUTICAL I… | $10K | $4.225 | Injection |
Chile 2 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| FRESENIUS KABI CHILE L… | FRESENIUS KABI ONCOL… | $33K | $16.631 | Injection |
| MSN LABS CHILE SPA | MSN LABORATORIES PVT… | $2K | $6.462 | Injection |
Kenya 2 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| NAIROBI ENTERPRISES LTD | GETWELL PHARMA INDIA… | $2K | $20.736 | Injection |
| SALAMA PHARMACUTICALS … | M T MADON EXPORTS | $306.310 | $5.569 | Injection |
Belgium 1 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| YUSEN LOGISTICS BENELU… | SUN PHARMACEUTICAL I… | $275K | $21.845 | Injection |
§6.3 Price positioning — top 25 importers
| # | Importer | Country | USD | $/ship | Tier |
|---|---|---|---|---|---|
| 1 | YUSEN LOGISTICS BENE… | Belgium | $275K | $92K | Premium |
| 2 | MEDIHOME LTD | Israel | $131K | $66K | Premium |
| 3 | SUN FARMACEUTICA DO … | Brazil | $126K | $31K | Mid |
| 4 | VIATRIS PHARMACEUTIC… | Thailand | $73K | $73K | Premium |
| 5 | FRESENIUS KABI DEUTS… | Germany | $41K | $14K | Budget |
| 6 | FRESENIUS KABI CHILE… | Chile | $33K | $33K | Mid |
| 7 | TRUST ANESTHETIC LTD | Afghanistan | $16K | $8K | Budget |
| 8 | PZAC CORP | Dominican Republic | $15K | $15K | Budget |
| 9 | GLENMARK PHARMACEUTI… | South Africa | $11K | $11K | Budget |
| 10 | SUN FARMACUTICA DO B… | Brazil | $10K | $10K | Budget |
| 11 | ESSENCE LIFE | Lebanon | $8K | $8K | Budget |
| 12 | MEDICAL STORES DEPAR… | Tanzania | $6K | $6K | Budget |
| 13 | MUBARAK HASHIMI LTD | Afghanistan | $4K | $1K | Budget |
| 14 | CENTRALE DACHATS DE … | Madagascar | $3K | $2K | Budget |
| 15 | SIJAL PHARMA PVT LTD | Nepal | $2K | $2K | Budget |
| 16 | NAIROBI ENTERPRISES … | Kenya | $2K | $2K | Budget |
| 17 | JSC RAFARMA | Russia | $2K | $402.000 | Budget |
| 18 | MSN LABS CHILE SPA | Chile | $2K | $2K | Budget |
| 19 | ETEMED MOSLEH LTD | Afghanistan | $2K | $2K | Budget |
| 20 | EUROFINS BIOPHARMA P… | Hungary | $1K | $1K | Budget |
| 21 | AL-NOOR FOR DRUGS & … | Yemen | $757.347 | $252.000 | Budget |
| 22 | ANSYNC GLOBAL FZCO | United Arab Emirates | $739.481 | $739.000 | Budget |
| 23 | ATLAS TRADING COMPANY | Iraq | $701.593 | $351.000 | Budget |
| 24 | MINISTRY OF HEALTH (… | Seychelles | $582.392 | $582.000 | Budget |
| 25 | BIO TECH PHARMA S.A | Costa Rica | $400.613 | $401.000 | Budget |
06
PART III — WHO’S IN THIS MARKET
Market Relationship Map
The top 20 × 20 supplier ↔ buyer network as a circular flow diagram
Fig 6.3 SUN PHARMACEUTICAL INDUSTRIES LTD → YUSEN LOGISTICS BENELUX BELGIUM is the strongest relationship.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left semicircle = top 20 Indian suppliers; right = top 20 global buyers. Arc length = total USD; colored ribbons = individual relationships, thickness = USD value. Insight: follow the thickest ribbons to identify the dominant trading pairs.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
How Indian bortezomib prices vary by supplier, country and dosage form
KEY TAKEAWAY
Bortezomib prices span 800112× ($0.031 → $25060.45). The coefficient of variation is 4.90. Dosage form, not destination, is the primary price driver.
S FOR SUPPLIERS
Use the box plot to see where your product sits on the price spectrum. The tornado chart shows exactly where you sit relative to the market median.
B FOR BUYERS
Use this section to benchmark the price you pay against the market. The percentile strip tells you if your current supplier is charging you premium, mid-market or budget rates.
§7.1 Price distribution · Table 7.1
| Statistic | Value | Interpretation |
|---|---|---|
| Min | $0.031 | Lowest observed unit price |
| P5 | $0.151 | 5th percentile |
| P25 | $3.98 | 25th percentile (Q1) |
| Median | $7.60 | 50th percentile (Q2) |
| P75 | $18.81 | 75th percentile (Q3) |
| P95 | $1.7K | 95th percentile |
| Max | $25.1K | Highest observed unit price |
| Mean | $687.24 | Arithmetic average |
| CV | 490% | Coefficient of variation (std/mean) |
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
Fig 7.1 J S LABS prices at $12K/unit vs market median $7.60.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar shows one supplier’s average unit price relative to the market median (dashed line). Red = above median (premium), green = below (budget).
COMMODITY KINGS
high volume · low unit price
Bulk API/tablet. Largest absolute USD despite lowest per-unit prices. e.g. FRESENIUS KABI ONCOLOGY Sourcing: best for cost-driven procurement.
BULK LEADERS
high volume · premium price
Branded-generic leaders, above-median pricing. e.g. SUN PHARMACEUTICAL INDUSTRIES Sourcing: hardest to displace; compete on relationship.
LONG-TAIL
low volume · low unit price
Spot/opportunistic players. e.g. GLENMARK PHARMACEUTICALS LTD Sourcing: first to approach for new tenders.
PREMIUM NICHE
low volume · premium price
Sterile injectables and infusions. Hospital-grade. e.g. MYLAN LABORATORIES LTD Sourcing: expect 10× price vs tablet.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
Outlier forensics and the procurement cheat sheet — what to expect to pay by country × dosage
KEY TAKEAWAY
Extreme prices are real: the highest are specialty/sterile formulations; the lowest are bulk API. The cheat sheet matrix is the take-home reference for procurement teams.
§7.2 Outlier forensics — top 10 highest and 10 lowest unit prices
↑ TOP 10 HIGHEST USD/UNIT
| Date | Exporter | Country | Dosage | Qty | USD | $/unit | Why |
|---|---|---|---|---|---|---|---|
| Oct 2025 | J S LABS | Russia | — | 0 | $1K | $25K | Specialty / small-batch |
| Oct 2025 | J S LABS | Russia | — | 0 | $491.99 | $16K | Specialty / small-batch |
| Oct 2025 | J S LABS | Russia | — | 0 | $334.16 | $11K | Specialty / small-batch |
| Oct 2025 | J S LABS | Russia | — | 0 | $97.94 | $5K | Specialty / small-batch |
| Oct 2025 | J S LABS | Russia | — | 0 | $84.11 | $3K | Specialty / small-batch |
| Nov 2025 | SUN PHARMACEUTIC… | Belgium | Injection | 4K | $180K | $44.82 | Sterile formulation premium |
| Nov 2025 | SUN PHARMACEUTIC… | Belgium | Injection | 4K | $180K | $44.82 | Sterile formulation premium |
| Oct 2025 | MYLAN LABORATORI… | Thailand | Injection | 2K | $73K | $31.09 | Sterile formulation premium |
| Nov 2025 | GETWELL PHARMA I… | Dominican Republic | Injection | 500 | $15K | $29.94 | Sterile formulation premium |
| Nov 2025 | GETWELL PHARMA I… | Dominican Republic | Injection | 500 | $15K | $29.94 | Sterile formulation premium |
↓ TOP 10 LOWEST USD/UNIT
| Date | Exporter | Country | Dosage | Qty | USD | $/unit | Why |
|---|---|---|---|---|---|---|---|
| Dec 2025 | SARTAJ PHARMA PV… | Afghanistan | Injection | 1K | $31.32 | $0.031 | Sterile formulation premium |
| Dec 2025 | GRAMEEN PHARMA LLP | Ghana | Injection | 30 | $2.94 | $0.098 | Sterile formulation premium |
| Dec 2025 | BIOZENTA LIFESCI… | Eswatini | Injection | 50 | $5.13 | $0.103 | Sterile formulation premium |
| Dec 2025 | RMPL PHARMA LLP | Lebanon | Injection | 50 | $5.42 | $0.108 | Sterile formulation premium |
| Dec 2025 | ATLAS ENTERPRISES | Mexico | Injection | 200 | $24.46 | $0.122 | Sterile formulation premium |
| Dec 2025 | GENETEC LIFESCIE… | Mali | — | 20 | $3.87 | $0.194 | Small sample / trial shipment |
| Dec 2025 | FRESENIUS KABI O… | Costa Rica | Injection | 2K | $400.61 | $0.200 | Sterile formulation premium |
| Dec 2025 | SANSKRUTI PHARMA | Burkina Faso | Injection | 40 | $8.58 | $0.214 | Sterile formulation premium |
| Dec 2025 | VENUS REMEDIES LTD | Morocco | Powder | 783 | $240.18 | $0.307 | Small sample / trial shipment |
| Nov 2025 | GLENMARK PHARMAC… | South Africa | Injection | 16K | $11K | $0.721 | Sterile formulation premium |
§7.3 Procurement cheat sheet — median USD/unit by country × dosage
Fig 7.2 Median unit price by country × dosage form — darker cells = higher prices.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each cell shows the median price per unit for that country-dosage combination. Dark blue = expensive, light = cheap. Blank cells = no shipments in that combination.
NEGOTIATION RANGE
Use each cell value as the anchor price. Typical dynamics:
- Budget buyer: anchor − 10–15% (floor = cost + freight)
- Mid-market: anchor ± 5–10%
- Premium/tender: anchor + 10–25% (regulated, quality premium)
- Injection/infusion: always 4–10× the tablet price
KEY TAKEAWAYS
- Dosage form is the #1 price driver, not destination
- Light cells = easy-entry markets for small suppliers
- Dark cells = premium markets requiring regulatory investment
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Which Indian ports ship bortezomib, which global ports receive it, and which corridors are high-value vs bulk
KEY TAKEAWAY
Bortezomib leaves India through 10+ ports. The top 5 (DELHI AIR, HYDERABAD AIR, BANGALORE AIR) handle 96.8% of total USD. AIR moves 88% of shipments.
S FOR SUPPLIERS
Use the dumbbell to classify your port as high-value hub or bulk workhorse. Note the short-sea routes — Bangladesh, Sri Lanka, Myanmar and East Africa are the easiest logistics corridors for first-time exporters.
B FOR BUYERS
Use the destination port ranking to find which Indian ports serve your market. The lead-time estimates tell you what transit time to expect.
Fig 8.1 DELHI AIR handles $770K — top 10 Indian origin ports by trade value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one Indian port. Bar length = USD value. The largest ports handle the majority of trade.
Fig 8.2 BRUSSELS is the #1 global destination port — top 25 by USD value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one destination port worldwide. Bar length = USD value received from India.
§8.1 Reference transit times for key India → global corridors
| Route | Mode | Transit time | Notes |
|---|---|---|---|
| NHAVA SHEVA SEA (JNPT) → US East Coast | Sea | 22–28 days | Via Suez; 2–3 transshipments typical |
| NHAVA SHEVA SEA (JNPT) → Lagos (Nigeria) | Sea | 18–24 days | Direct liner service available |
| MUMBAI AIR (SAHAR) → New York JFK | Air | 3–5 days | Direct cargo; cold-chain available |
| MUNDRA SEA → Rotterdam | Sea | 20–26 days | Via Suez; Hamburg also served |
| HYDERABAD AIR → London Heathrow | Air | 2–4 days | Pharma-grade cargo corridor |
| CHENNAI SEA → Chittagong (Bangladesh) | Sea | 7–12 days | Short-sea route; high frequency |
| RAXAUL → Birgunj (Nepal) | Road | 1–2 days | Land border crossing |
| NHAVA SHEVA SEA (JNPT) → Mombasa (Kenya) | Sea | 14–20 days | Direct or via Colombo hub |
Table 8.1 — Reference times based on standard shipping corridors. Air = 2–5 days; sea = 7–28 days; road = 1–2 days. Add 3–7 days for customs clearance at destination.
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Trade corridors — origin port to mode of transport to destination region
KEY TAKEAWAY
AIR dominates at 88% of shipments. The alluvial traces every dollar from Indian origin port through transport mode to destination region.
AIR
$1.0M
92.9% of USD · 87.6% of ships
ICD
$48K
4.4% of USD · 10.1% of ships
SEA
$30K
2.7% of USD · 2.2% of ships
Fig 8.3 The dominant corridor is DELHI AIR → Air → Europe ($498K).
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian origin ports. Middle = transport mode. Right = destination region. Ribbon thickness = USD value; color = mode. Follow the thickest ribbons to find the highest-value corridors.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market concentration, supply-chain risk, and the dependency patterns that signal where to act
KEY TAKEAWAY
Brazil is the most concentrated destination (HHI 10000, 1 suppliers). Afghanistan is the most competitive (HHI 4679).
S FOR SUPPLIERS
The HHI barbell shows where competitors have locked up a market (concentrated = poaching opportunity) vs where you must compete on quality (fragmented). The slope chart reveals who is gaining ground.
B FOR BUYERS
The HHI barbell tells you whether your country has enough supplier options. If concentrated (red zone), you have fewer alternatives.
Fig 9.1 Brazil (HHI 10,000) is the most concentrated — Afghanistan (HHI 4,679) is the most competitive.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
What is HHI? The Herfindahl-Hirschman Index measures how concentrated a market is among its suppliers. It ranges from 0 to 10,000. Below 1,500 (green zone) = many suppliers compete openly — healthy, competitive market with low risk. 1,500–2,500 (yellow zone) = a few suppliers hold significant share — moderate concentration. Above 2,500 (red zone) = one or two suppliers dominate the market — high risk for buyers who may lose supply, and hard to break into for new suppliers. Conclusion: 20 of 20 destination markets are concentrated (red zone). 0 are competitive (green zone). Buyers in red-zone markets should urgently qualify a second Indian supplier to reduce dependency risk.
§9.1 Single-source dependencies
| Buyer | Country | Sole supplier | USD | Ships | Risk |
|---|---|---|---|---|---|
| YUSEN LOGISTICS BENE… | Belgium | SUN PHARMACEUTIC… | $275K | 3 | HIGH |
| MEDIHOME LTD | Israel | MSN LABORATORIES… | $131K | 2 | HIGH |
| SUN FARMACEUTICA DO … | Brazil | SUN PHARMACEUTIC… | $126K | 4 | HIGH |
| VIATRIS PHARMACEUTIC… | Thailand | MYLAN LABORATORI… | $73K | 1 | MEDIUM |
| FRESENIUS KABI DEUTS… | Germany | FRESENIUS KABI O… | $41K | 3 | MEDIUM |
| FRESENIUS KABI CHILE… | Chile | FRESENIUS KABI O… | $33K | 1 | MEDIUM |
| PZAC CORP | Dominican Republic | GETWELL PHARMA I… | $15K | 1 | MEDIUM |
| GLENMARK PHARMACEUTI… | South Africa | GLENMARK PHARMAC… | $11K | 1 | MEDIUM |
Conclusion: 32 buyers depend on exactly one Indian supplier, representing $752K in trade. For suppliers: each row is a competitor’s locked-in customer you can target.
§9.2 Multi-source resilience
| Buyer | Country | Suppliers | USD | Dominant | Resilience |
|---|
Conclusion: 0 of these buyers have HIGH resilience (3+ active suppliers). These are the hardest accounts to win but safest partners for long-term contracts.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market entry playbook and risk landscape by destination country
KEY TAKEAWAY
15 target markets with specific entry approaches. Large suppliers: focus on regulated Tier 1 markets. Small/mid-size: start with Tier 2–3 (low barrier, growing demand).
§9.3 Sourcing recommendations · Table 9.1
| Country | Tier | Lead | Price | Risk | Entry approach |
|---|---|---|---|---|---|
| Belgium | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Brazil | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Israel | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Thailand | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Germany | Tier 3 (emerging) | 14–28 days (sea) | $1–$10/unit | LOW | First-mover advantage |
| Chile | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Afghanistan | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Dominican Republic | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Lesotho | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| South Africa | Tier 3 (emerging) | 3–5 days (air) | $0.10–$1/unit | LOW | First-mover advantage |
| Mexico | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Lebanon | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Tanzania | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Kenya | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Burkina Faso | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
For suppliers: Tier 1 markets (US, UK, France) require regulatory investment but offer premium pricing. Tier 3 markets (emerging) have low barriers — ideal for first-time exporters. For buyers: Use the price band and lead time to benchmark your current supplier’s terms.
Fig 9.2 0 markets in the Growth Opportunity zone (competitive + growing). 15 in Fragile Dependency (concentrated + shrinking).
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bubble = one destination. X-axis = HHI (concentration). Y-axis = growth %. Bubble size = USD. Green zone (top-left) = Growth Opportunity — competitive markets that are growing, best for new entrants. Red zone (bottom-right) = Fragile Dependency — concentrated + shrinking, high supply-chain risk. Conclusion: Key markets are the top growth opportunities.
09
PART V — ACTION
Action Plan & Easy-Entry Markets
12 prioritised actions + 15 low-competition destination countries for small & mid-size suppliers
KEY TAKEAWAY
Quick Wins: execute this quarter. Big Bets: plan for next 6–12 months. Plus 15 countries with ≤5 Indian suppliers — the best entry points for SMEs.
S
FOR SUPPLIERS
| ID | Action | Timing | Impact |
|---|---|---|---|
| A1 | Pitch top single-source buyer in Belgium | This Q | HIGH |
| A2 | Offer alternative to top multi-source buyer | This Q | HIGH |
| A3 | Audit Brazil lock-ins (HHI 10000) | This Q | MED |
| A5 | Enter Belgium (1 suppliers) | This Q | HIGH |
| A6 | Enter Brazil (1 suppliers) | This Q | MED |
| A8 | Build Brazil distribution | 6–12m | HIGH |
| A9 | Bundle injection/infusion catalog for premium markets | 6–12m | MED |
B
FOR BUYERS
| ID | Action | Timing | Impact |
|---|---|---|---|
| A4 | Monitor rising exporters (climbers) | This Q | MED |
| A7 | Register for Belgium tenders | 6–12m | HIGH |
| A10 | Track quarterly HHI shifts across key destinations | This Q | LOW |
| A11 | Map competitor buyer portfolios quarterly | This Q | MED |
| A12 | Qualify second source for single-source buyers | This Q | MED |
§9.4 Easy-entry markets — 15 countries with ≤5 Indian suppliers
| # | Country | Region | Suppliers | Q4 USD | Growth | Barrier | Why this is easy |
|---|---|---|---|---|---|---|---|
| 1 | Belgium | Other | 1 | $523K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 2 | Brazil | Other | 1 | $151K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 3 | Israel | Other | 1 | $131K | -100% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 4 | Thailand | Asia | 1 | $73K | -100% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 5 | Germany | Other | 1 | $41K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 6 | Chile | Other | 2 | $35K | 0% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 7 | Dominican Republic | Other | 1 | $30K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 8 | Lesotho | Africa | 1 | $11K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 9 | South Africa | Africa | 1 | $11K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 10 | Mexico | Other | 3 | $9K | 0% | LOW | Low competition (3 suppliers), accessible market |
| 11 | Lebanon | Other | 2 | $8K | -99.9% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 12 | Tanzania | Africa | 1 | $6K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 13 | Kenya | Africa | 3 | $6K | 0% | LOW | Low competition (3 suppliers), accessible market |
| 14 | Burkina Faso | Africa | 1 | $3K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 15 | Madagascar | Africa | 1 | $3K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
This report covers 89 2025-Q4 Bortezomib shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/bortezomib
10
PART VI — EVIDENCE REGISTER
Comprehensive Shipment Records by Region
Authoritative source behind all analytics in this report — every shipment appears exactly once
KEY TAKEAWAY
This section contains every one of the 89 2025-Q4 bortezomib shipments, organised by Region → Exporter → Shipment rows. No row is duplicated.
S FOR SUPPLIERS
Jump to any destination country to see exactly who your competitors ship to, what they charge, through which port, and how often.
B FOR BUYERS
Jump to your country to see every Indian bortezomib shipment that arrived in 2025-Q4: supplier, price, dosage, port.
§10.1 Global totals
SHIPMENTS
89
across all regions
TOTAL USD
$1.09M
2025-Q4 FOB value
UNITS
111.8K
tablets, capsules, etc.
SUPPLIERS
41
Indian exporters
BUYERS
36
global importers
COUNTRIES
39
destinations
§10.2 Regional breakdown
§10.3 Key insights from the data
Africa is the largest region at $44K (4.1%), spanning 16 countries.
41 Indian suppliers shipped to 36 buyers across 39 countries — average shipment value $12K.
Top 0 markets: .
Every row below is real customs data — date, importer, dosage, brand, quantity, unit price, total USD, origin port, destination port, and transport mode.
§10.4 How to read a country page
1
6 KPI cards — shipments, USD, qty, exporters, importers, avg unit price.
2
4 mini-lists — top exporters, importers, dosages, monthly trend.
3
Shipment register — every row grouped by exporter. No row is duplicated or omitted.
10
PART VI — DRILL-DOWN · AFRICA
Region: Africa
16 countries · 28 shipments · $44K · 16 Indian suppliers · 11 buyers
SHIPMENTS
28
USD
$44K
COUNTRIES
16
SUPPLIERS
16
BUYERS
11
HHI
1,757
moderate
Top 16 destination countries in Africa
1
Lesotho (25.8%)
$11K
2
South Africa (25.1%)
$11K
3
Tanzania (13.8%)
$6K
4
Kenya (12.7%)
$6K
5
Burkina Faso (6.9%)
$3K
6
Madagascar (6.9%)
$3K
7
Mauritius (5.4%)
$2K
8
Seychelles (1.3%)
$582.39
9
Ethiopia (0.7%)
$307.23
10
Cameroon (0.6%)
$244.78
11
Morocco (0.5%)
$240.18
12
Zambia (0.2%)
$79.57
13
Eswatini (0.0%)
$5.13
14
Mali (0.0%)
$3.87
15
Ghana (0.0%)
$2.94
16
DR Congo (0.0%)
$1.72
Top 16 Indian suppliers into Africa
1
BRUCK PHARMA PVT LTD
$11K
2
GLENMARK PHARMACEUTICALS LTD
$11K
3
ARECHAR HEALTHCARE LLP
$6K
4
GETWELL PHARMA INDIA PVT LTD
$5K
5
R.S. SURGIPHARM PVT LTD
$3K
6
SANSKRUTI PHARMA
$3K
7
BIOZENTA LIFESCIENCE PVT LTD
$2K
8
SAYAR LIFE-CARE
$582.39
9
MATOSHREE HEALTH CARE PVT LTD
$307.23
10
M T MADON EXPORTS
$306.31
11
RUN MEDWAY
$244.78
12
VENUS REMEDIES LTD
$240.18
13
MEDICOS LIFESCIENCES
$79.57
14
GENETEC LIFESCIENCES
$3.87
15
GRAMEEN PHARMA LLP
$2.94
16
YOGI CARE PHARMACEUTICAL PVT LTD
$1.72
Top 9 Africa importers
1
GLENMARK PHARMACEUTICALS SOUTH · South Africa
$11K
2
MEDICAL STORES DEPARTMENT · Tanzania
$6K
3
CENTRALE DACHATS DE MEDICAMENTS · Madagascar
$3K
4
NAIROBI ENTERPRISES LTD · Kenya
$2K
5
MINISTRY OF HEALTH ( CLAUDE JULIEN · Seychelles
$582.39
6
SALAMA PHARMACUTICALS LTD · Kenya
$306.31
7
CLYZ PHARMA SARL · Cameroon
$244.78
8
LUSAKA PHARMA CHEM SUPPLIES LTD · Zambia
$79.57
9
THE MANAGER SA · Ghana
$2.94
Top 4 dosage forms
1
Injection
$44K
2
Vial
$582.39
3
Powder
$240.18
4
Unknown
$3.87
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 1 | $1.72 | $1.72 |
| Nov | 13 | $40K | $3K |
| Dec | 14 | $4K | $318.60 |
Shipment register · 28 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — BRUCK PHARMA PVT LTD · 2 shipments · $11K | |||||||||||
| 1 | Nov 2025 | UNLISTED BUYER | Lesotho | Injection | 200 | NOS | $28.70 | $6K | MUMBAI AIR (SAHAR) | MASERU | AIR |
| 2 | Nov 2025 | UNKNOWN BUYER | Lesotho | Injection | 200 | NOS | $28.70 | $6K | MUMBAI AIR (SAHAR) | MASERU | AIR |
| SUPPLIER #2 — GLENMARK PHARMACEUTICALS LTD · 1 shipments · $11K | |||||||||||
| 3 | Nov 2025 | GLENMARK PHARMACEUTICALS SOUTH | South Africa | Injection | 15.5K | NOS | $0.721 | $11K | DELHI AIR | JOHANNESBURG - JOHAN | AIR |
| SUPPLIER #3 — ARECHAR HEALTHCARE LLP · 1 shipments · $6K | |||||||||||
| 4 | Nov 2025 | MEDICAL STORES DEPARTMENT | Tanzania | Injection | 236 | NOS | $26.04 | $6K | DELHI AIR | DAR ES SALAM (DARESS | AIR |
| SUPPLIER #4 — GETWELL PHARMA INDIA PVT LTD · 3 shipments · $5K | |||||||||||
| 5 | Nov 2025 | CENTRALE DACHATS DE MEDICAMENTS | Madagascar | Injection | 200 | NOS | $7.92 | $2K | DELHI AIR | ANTANANARIVO | AIR |
| 6 | Nov 2025 | CENTRALE DACHATS DE MEDICAMENTS | Madagascar | Injection | 200 | NOS | $7.35 | $1K | DELHI AIR | ANTANANARIVO | AIR |
| 7 | Nov 2025 | NAIROBI ENTERPRISES LTD | Kenya | Injection | 100 | NOS | $20.74 | $2K | DELHI AIR | NAIROBI | AIR |
| SUPPLIER #5 — R.S. SURGIPHARM PVT LTD · 4 shipments · $3K | |||||||||||
| 8 | Dec 2025 | UNKNOWN BUYER | Kenya | Injection | 80 | VLS | $10.73 | $858.18 | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| 9 | Dec 2025 | UNKNOWN BUYER | Kenya | Injection | 100 | VLS | $6.29 | $628.68 | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| 10 | Dec 2025 | UNKNOWN BUYER | Kenya | Injection | 17 | VLS | $5.92 | $100.71 | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| 11 | Dec 2025 | UNKNOWN BUYER | Kenya | Injection | 150 | VLS | $11.16 | $2K | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| SUPPLIER #6 — SANSKRUTI PHARMA · 5 shipments · $3K | |||||||||||
| 12 | Nov 2025 | UNLISTED BUYER | Burkina Faso | Injection | 40 | VLS | $19.79 | $791.71 | MUMBAI AIR (SAHAR) | OUAGADOUGOU | AIR |
| 13 | Nov 2025 | UNLISTED BUYER | Burkina Faso | Injection | 40 | VLS | $19.03 | $761.22 | MUMBAI AIR (SAHAR) | OUAGADOUGOU | AIR |
| 14 | Nov 2025 | UNKNOWN BUYER | Burkina Faso | Injection | 40 | VLS | $19.03 | $761.22 | MUMBAI AIR (SAHAR) | OUAGADOUGOU | AIR |
| 15 | Nov 2025 | UNLISTED BUYER | Burkina Faso | Injection | 40 | VLS | $19.03 | $761.16 | MUMBAI AIR (SAHAR) | OUAGADOUGOU | AIR |
| 16 | Dec 2025 | UNLISTED BUYER | Burkina Faso | Injection | 40 | VLS | $0.214 | $8.58 | MUMBAI AIR (SAHAR) | OUAGADOUGOU | AIR |
| SUPPLIER #7 — BIOZENTA LIFESCIENCE PVT LTD · 2 shipments · $2K | |||||||||||
| 17 | Nov 2025 | UNLISTED BUYER | Mauritius | Injection | 300 | NOS | $8.06 | $2K | DELHI AIR | MAURITIUS | AIR |
| 18 | Dec 2025 | UNLISTED BUYER | Eswatini | Injection | 50 | NOS | $0.103 | $5.13 | DELHI AIR | MATADI | AIR |
| SUPPLIER #8 — SAYAR LIFE-CARE · 1 shipments · $582.39 | |||||||||||
| 19 | Nov 2025 | MINISTRY OF HEALTH ( CLAUDE JULIEN | Seychelles | Vial | 24 | NOS | $24.27 | $582.39 | CHENNAI AIR | MAHE ISLAND | AIR |
| SUPPLIER #9 — MATOSHREE HEALTH CARE PVT LTD · 1 shipments · $307.23 | |||||||||||
| 20 | Dec 2025 | UNKNOWN BUYER | Ethiopia | Injection | 30 | NOS | $10.24 | $307.23 | MUMBAI AIR (SAHAR) | ADDIS ABABA | AIR |
| SUPPLIER #10 — M T MADON EXPORTS · 2 shipments · $306.31 | |||||||||||
| 21 | Dec 2025 | SALAMA PHARMACUTICALS LTD | Kenya | Injection | 20 | NOS | $4.04 | $80.87 | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| 22 | Dec 2025 | SALAMA PHARMACUTICALS LTD | Kenya | Injection | 35 | NOS | $6.44 | $225.44 | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| SUPPLIER #11 — RUN MEDWAY · 1 shipments · $244.78 | |||||||||||
| 23 | Dec 2025 | CLYZ PHARMA SARL | Cameroon | Injection | 30 | NOS | $8.16 | $244.78 | MUMBAI AIR (SAHAR) | DOUALA | AIR |
| SUPPLIER #12 — VENUS REMEDIES LTD · 1 shipments · $240.18 | |||||||||||
| 24 | Dec 2025 | UNKNOWN BUYER | Morocco | Powder | 783 | NOS | $0.307 | $240.18 | DELHI AIR | CASABLANCA | AIR |
| SUPPLIER #13 — MEDICOS LIFESCIENCES · 1 shipments · $79.57 | |||||||||||
| 25 | Dec 2025 | LUSAKA PHARMA CHEM SUPPLIES LTD | Zambia | Injection | 20 | NOS | $3.98 | $79.57 | AHMEDABAD AIR | LUSAKA | AIR |
| SUPPLIER #14 — GENETEC LIFESCIENCES · 1 shipments · $3.87 | |||||||||||
| 26 | Dec 2025 | UNLISTED BUYER | Mali | 20 | NOS | $0.194 | $3.87 | MUMBAI AIR (SAHAR) | BAMAKO | AIR | |
| SUPPLIER #15 — GRAMEEN PHARMA LLP · 1 shipments · $2.94 | |||||||||||
| 27 | Dec 2025 | THE MANAGER SA | Ghana | Injection | 30 | NOS | $0.098 | $2.94 | MUMBAI AIR (SAHAR) | ACCRA | AIR |
| SUPPLIER #16 — YOGI CARE PHARMACEUTICAL PVT LTD · 1 shipments · $1.72 | |||||||||||
| 28 | Oct 2025 | UNLISTED BUYER | DR Congo | Injection | 2 | NOS | $0.862 | $1.72 | AHMEDABAD AIR | LUMBUMBASHI | AIR |
10
PART VI — DRILL-DOWN · ASIA
Region: Asia
11 countries · 26 shipments · $254K · 18 Indian suppliers · 15 buyers
SHIPMENTS
26
USD
$254K
COUNTRIES
11
SUPPLIERS
18
BUYERS
15
HHI
3,585
concentrated
Top 11 destination countries in Asia
1
Israel (51.7%)
$131K
2
Thailand (28.7%)
$73K
3
Afghanistan (12.8%)
$33K
4
Lebanon (3.2%)
$8K
5
Myanmar (1.2%)
$3K
6
Nepal (0.9%)
$2K
7
Tajikistan (0.5%)
$1K
8
United Arab Emirates (0.4%)
$1K
9
Yemen (0.3%)
$757.35
10
Iraq (0.3%)
$701.59
11
Turkey (0.1%)
$190.07
Top 18 Indian suppliers into Asia
1
MSN LABORATORIES PVT LTD
$131K
2
MYLAN LABORATORIES LTD
$73K
3
SAMARTH LIFE SCIENCES PVT LTD
$21K
4
THERDOSE PHARMA PVT LTD
$8K
5
KWALITY PHARMACEUTICALS LTD
$5K
6
KERK
$4K
7
BRUCK PHARMA PVT LTD
$3K
8
ADLEY FORMULATIONS PVT LTD
$2K
9
RESCUERS LIFE SCIENCES LTD
$2K
10
GALAXY SUPER SPECIALITY
$1K
11
J.A. UNITED EXPORTS PVT LTD
$757.35
12
OCEAN PHARMACEUTICAL
$739.48
13
VATS INDUSTRIES PVT LTD
$701.59
14
MEDMATRIX ASSOCIATES
$306.15
15
SEATRACK INTERNATIONAL TRADEX PVT LTD
$207.17
16
RMPL PHARMA LLP
$195.49
17
HUMANKIND PHARMA
$63.98
18
SARTAJ PHARMA PVT LTD
$31.32
Top 13 Asia importers
1
MEDIHOME LTD · Israel
$131K
2
VIATRIS PHARMACEUTICALS (THAILAND) · Thailand
$73K
3
TRUST ANESTHETIC LTD · Afghanistan
$16K
4
ESSENCE LIFE · Lebanon
$8K
5
MUBARAK HASHIMI LTD · Afghanistan
$4K
6
SIJAL PHARMA PVT LTD · Nepal
$2K
7
ETEMED MOSLEH LTD · Afghanistan
$2K
8
AL-NOOR FOR DRUGS & MEDICAL APPLIAN · Yemen
$757.35
9
ANSYNC GLOBAL FZCO · United Arab Emirates
$739.48
10
ATLAS TRADING COMPANY · Iraq
$701.59
11
GULF IMPEX FZC · Afghanistan
$306.15
12
ZMC EXPRESS CARGO FZCO · United Arab Emirates
$271.16
13
SARTAJ ENTERPRISES LTD · Afghanistan
$31.32
Top 2 dosage forms
1
Vial
$131K
2
Injection
$123K
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 4 | $213K | $53K |
| Nov | 7 | $31K | $4K |
| Dec | 15 | $11K | $711.08 |
Shipment register · 26 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — MSN LABORATORIES PVT LTD · 2 shipments · $131K | |||||||||||
| 1 | Oct 2025 | MEDIHOME LTD | Israel | Vial | 3.4K | NOS | $19.82 | $66K | HYDERABAD AIR | TEL AVIV YAFO | AIR |
| 2 | Oct 2025 | MEDIHOME LTD | Israel | Vial | 3.3K | NOS | $19.82 | $65K | HYDERABAD AIR | TEL AVIV YAFO | AIR |
| SUPPLIER #2 — MYLAN LABORATORIES LTD · 1 shipments · $73K | |||||||||||
| 3 | Oct 2025 | VIATRIS PHARMACEUTICALS (THAILAND) | Thailand | Injection | 2.4K | NOS | $31.09 | $73K | BANGALORE AIR | BANGKOK | AIR |
| SUPPLIER #3 — SAMARTH LIFE SCIENCES PVT LTD · 2 shipments · $21K | |||||||||||
| 4 | Nov 2025 | TRUST ANESTHETIC LTD | Afghanistan | Injection | 3.0K | NOS | $3.53 | $11K | DELHI AIR | KABUL | AIR |
| 5 | Nov 2025 | UNKNOWN BUYER | Afghanistan | Injection | 3.0K | NOS | $3.53 | $11K | DELHI AIR | KABUL | AIR |
| SUPPLIER #4 — THERDOSE PHARMA PVT LTD · 1 shipments · $8K | |||||||||||
| 6 | Oct 2025 | ESSENCE LIFE | Lebanon | Injection | 546 | NOS | $14.86 | $8K | HYDERABAD AIR | BEIRUT | AIR |
| SUPPLIER #5 — KWALITY PHARMACEUTICALS LTD · 1 shipments · $5K | |||||||||||
| 7 | Nov 2025 | TRUST ANESTHETIC LTD | Afghanistan | Injection | 3.0K | NOS | $1.65 | $5K | DELHI AIR | KABUL | AIR |
| SUPPLIER #6 — KERK · 3 shipments · $4K | |||||||||||
| 8 | Dec 2025 | MUBARAK HASHIMI LTD | Afghanistan | Injection | 300 | NOS | $3.35 | $1K | TUGHLAKABAD ICD | Kandahar | ICD |
| 9 | Dec 2025 | MUBARAK HASHIMI LTD | Afghanistan | Injection | 486 | NOS | $3.35 | $2K | TUGHLAKABAD ICD | Kandahar | ICD |
| 10 | Dec 2025 | MUBARAK HASHIMI LTD | Afghanistan | Injection | 500 | NOS | $3.35 | $2K | TUGHLAKABAD ICD | Kandahar | ICD |
| SUPPLIER #7 — BRUCK PHARMA PVT LTD · 1 shipments · $3K | |||||||||||
| 11 | Nov 2025 | UNLISTED BUYER | Myanmar | Injection | 300 | NOS | $10.00 | $3K | MUMBAI AIR (SAHAR) | YANGON | AIR |
| SUPPLIER #8 — ADLEY FORMULATIONS PVT LTD · 1 shipments · $2K | |||||||||||
| 12 | Dec 2025 | SIJAL PHARMA PVT LTD | Nepal | Injection | 300 | NOS | $7.64 | $2K | DELHI AIR | KATHMANDU - TRIBHUVA | SEA |
| SUPPLIER #9 — RESCUERS LIFE SCIENCES LTD · 1 shipments · $2K | |||||||||||
| 13 | Dec 2025 | ETEMED MOSLEH LTD | Afghanistan | Injection | 500 | NOS | $3.50 | $2K | DELHI AIR | KABUL | AIR |
| SUPPLIER #10 — GALAXY SUPER SPECIALITY · 1 shipments · $1K | |||||||||||
| 14 | Nov 2025 | UNLISTED BUYER | Tajikistan | Injection | 200 | NOS | $6.16 | $1K | DELHI AIR | TASHKENT | AIR |
| SUPPLIER #11 — J.A. UNITED EXPORTS PVT LTD · 3 shipments · $757.35 | |||||||||||
| 15 | Nov 2025 | AL-NOOR FOR DRUGS & MEDICAL APPLIAN | Yemen | Injection | 100 | NOS | $6.18 | $617.61 | MUMBAI AIR (SAHAR) | ADEN | AIR |
| 16 | Dec 2025 | AL-NOOR FOR DRUGS & MEDICAL APPLIAN | Yemen | Injection | 10 | NOS | $6.06 | $60.59 | MUMBAI AIR (SAHAR) | ADEN | AIR |
| 17 | Dec 2025 | AL-NOOR FOR DRUGS & MEDICAL APPLIAN | Yemen | Injection | 10 | NOS | $7.92 | $79.15 | MUMBAI AIR (SAHAR) | ADEN | AIR |
| SUPPLIER #12 — OCEAN PHARMACEUTICAL · 1 shipments · $739.48 | |||||||||||
| 18 | Dec 2025 | ANSYNC GLOBAL FZCO | United Arab Emirates | Injection | 50 | NOS | $14.79 | $739.48 | AHMEDABAD AIR | SHARJAH | AIR |
| SUPPLIER #13 — VATS INDUSTRIES PVT LTD · 2 shipments · $701.59 | |||||||||||
| 19 | Dec 2025 | ATLAS TRADING COMPANY | Iraq | Injection | 50 | NOS | $7.02 | $350.80 | DELHI AIR | BAGDAD, METROPOLITAN | AIR |
| 20 | Dec 2025 | ATLAS TRADING COMPANY | Iraq | Injection | 50 | NOS | $7.02 | $350.80 | DELHI AIR | BAGDAD, METROPOLITAN | AIR |
| SUPPLIER #14 — MEDMATRIX ASSOCIATES · 1 shipments · $306.15 | |||||||||||
| 21 | Dec 2025 | GULF IMPEX FZC | Afghanistan | Injection | 50 | NOS | $6.12 | $306.15 | DADRI ICD | KABUL | ICD |
| SUPPLIER #15 — SEATRACK INTERNATIONAL TRADEX PVT LTD · 1 shipments · $207.17 | |||||||||||
| 22 | Dec 2025 | ZMC EXPRESS CARGO FZCO | United Arab Emirates | Injection | 30 | NOS | $6.91 | $207.17 | DELHI AIR | DUBAI | AIR |
| SUPPLIER #16 — RMPL PHARMA LLP · 2 shipments · $195.49 | |||||||||||
| 23 | Dec 2025 | UNLISTED BUYER | Lebanon | Injection | 50 | NOS | $0.108 | $5.42 | MUMBAI AIR (SAHAR) | BEIRUT | AIR |
| 24 | Dec 2025 | UNLISTED BUYER | Turkey | Injection | 25 | NOS | $7.60 | $190.07 | MUMBAI AIR (SAHAR) | ADANA | AIR |
| SUPPLIER #17 — HUMANKIND PHARMA · 1 shipments · $63.98 | |||||||||||
| 25 | Nov 2025 | ZMC EXPRESS CARGO FZCO | United Arab Emirates | Injection | 30 | NOS | $2.13 | $63.98 | MUMBAI AIR (SAHAR) | DUBAI WORLD CENTRAL | AIR |
| SUPPLIER #18 — SARTAJ PHARMA PVT LTD · 1 shipments · $31.32 | |||||||||||
| 26 | Dec 2025 | SARTAJ ENTERPRISES LTD | Afghanistan | Injection | 1.0K | NOS | $0.031 | $31.32 | TUGHLAKABAD ICD | Kandahar | ICD |
10
PART VI — DRILL-DOWN · EUROPE
Region: Europe
4 countries · 15 shipments · $568K · 3 Indian suppliers · 5 buyers
SHIPMENTS
15
USD
$568K
COUNTRIES
4
SUPPLIERS
3
BUYERS
5
HHI
8,517
concentrated
Top 4 destination countries in Europe
1
Belgium (92.0%)
$523K
2
Germany (7.2%)
$41K
3
Hungary (0.5%)
$3K
4
Russia (0.4%)
$2K
Top 3 Indian suppliers into Europe
1
SUN PHARMACEUTICAL INDUSTRIES LTD
$523K
2
FRESENIUS KABI ONCOLOGY LTD
$44K
3
J S LABS
$2K
Top 4 Europe importers
1
YUSEN LOGISTICS BENELUX BELGIUM · Belgium
$275K
2
FRESENIUS KABI DEUTSCHLAND GMBH · Germany
$41K
3
JSC RAFARMA · Russia
$2K
4
EUROFINS BIOPHARMA PRODUCT TESTING · Hungary
$1K
Top 2 dosage forms
1
Injection
$566K
2
Unknown
$2K
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 5 | $2K | $402.12 |
| Nov | 7 | $525K | $75K |
| Dec | 3 | $41K | $14K |
Shipment register · 15 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — SUN PHARMACEUTICAL INDUSTRIES LTD · 5 shipments · $523K | |||||||||||
| 1 | Nov 2025 | YUSEN LOGISTICS BENELUX BELGIUM | Belgium | Injection | 2.5K | NOS | $10.77 | $27K | NHAVA SHEVA SEA (JNPT) | Antwerpen | SEA |
| 2 | Nov 2025 | YUSEN LOGISTICS BENELUX BELGIUM | Belgium | Injection | 4.0K | VLS | $44.82 | $180K | DELHI AIR | BRUSSELS | AIR |
| 3 | Nov 2025 | UNKNOWN BUYER | Belgium | Injection | 4.0K | VLS | $44.82 | $180K | DELHI AIR | BRUSSELS | AIR |
| 4 | Nov 2025 | YUSEN LOGISTICS BENELUX BELGIUM | Belgium | Injection | 6.0K | VLS | $11.18 | $68K | DELHI AIR | BRUSSELS | AIR |
| 5 | Nov 2025 | UNKNOWN BUYER | Belgium | Injection | 6.0K | VLS | $11.18 | $68K | DELHI AIR | BRUSSELS | AIR |
| SUPPLIER #2 — FRESENIUS KABI ONCOLOGY LTD · 5 shipments · $44K | |||||||||||
| 6 | Nov 2025 | EUROFINS BIOPHARMA PRODUCT TESTING | Hungary | Injection | 348 | VLS | $3.83 | $1K | DELHI AIR | BUDAPEST, | AIR |
| 7 | Nov 2025 | UNKNOWN BUYER | Hungary | Injection | 348 | VLS | $3.83 | $1K | DELHI AIR | BUDAPEST, | AIR |
| 8 | Dec 2025 | FRESENIUS KABI DEUTSCHLAND GMBH | Germany | Injection | 4.7K | NOS | $5.10 | $24K | DADRI ICD | HAMBURG | ICD |
| 9 | Dec 2025 | FRESENIUS KABI DEUTSCHLAND GMBH | Germany | Injection | 1.1K | NOS | $4.97 | $5K | DADRI ICD | HAMBURG | ICD |
| 10 | Dec 2025 | FRESENIUS KABI DEUTSCHLAND GMBH | Germany | Injection | 2.3K | NOS | $4.97 | $11K | DADRI ICD | HAMBURG | ICD |
| SUPPLIER #3 — J S LABS · 5 shipments · $2K | |||||||||||
| 11 | Oct 2025 | JSC RAFARMA | Russia | 0 | GMS | $5K | $97.94 | HYDERABAD AIR | SHEREMETYEVO | AIR | |
| 12 | Oct 2025 | JSC RAFARMA | Russia | 0 | GMS | $3K | $84.11 | HYDERABAD AIR | SHEREMETYEVO | AIR | |
| 13 | Oct 2025 | JSC RAFARMA | Russia | 0 | GMS | $25K | $1K | HYDERABAD AIR | SHEREMETYEVO | AIR | |
| 14 | Oct 2025 | JSC RAFARMA | Russia | 0 | GMS | $11K | $334.16 | HYDERABAD AIR | SHEREMETYEVO | AIR | |
| 15 | Oct 2025 | JSC RAFARMA | Russia | 0 | GMS | $16K | $491.99 | HYDERABAD AIR | SHEREMETYEVO | AIR | |
10
PART VI — DRILL-DOWN · AMERICAS
Region: Americas
7 countries · 19 shipments · $226K · 9 Indian suppliers · 10 buyers
SHIPMENTS
19
USD
$226K
COUNTRIES
7
SUPPLIERS
9
BUYERS
10
HHI
4,885
concentrated
Top 7 destination countries in Americas
1
Brazil (66.9%)
$151K
2
Chile (15.6%)
$35K
3
Dominican Republic (13.3%)
$30K
4
Mexico (4.0%)
$9K
5
Costa Rica (0.2%)
$400.61
6
Saint Kitts and Nevis (0.1%)
$188.11
7
Cayman Islands (0.0%)
$82.68
Top 9 Indian suppliers into Americas
1
SUN PHARMACEUTICAL INDUSTRIES LTD
$151K
2
FRESENIUS KABI ONCOLOGY LTD
$34K
3
GETWELL PHARMA INDIA PVT LTD
$30K
4
MYGENIC HEALTHCARE PVT LTD
$8K
5
MSN LABORATORIES PVT LTD
$2K
6
MEDINEX HEALTHCARE
$979.07
7
P.K.EXPORTS
$188.11
8
MILES INTERNATIONAL
$82.68
9
ATLAS ENTERPRISES
$24.46
Top 8 Americas importers
1
SUN FARMACEUTICA DO BRASIL LTDA · Brazil
$126K
2
FRESENIUS KABI CHILE LTDA · Chile
$33K
3
PZAC CORP · Dominican Republic
$15K
4
SUN FARMACUTICA DO BRASIL LTDA · Brazil
$10K
5
MSN LABS CHILE SPA · Chile
$2K
6
BIO TECH PHARMA S.A · Costa Rica
$400.61
7
DRYANELIS LEON · Saint Kitts and Nevis
$188.11
8
DISTRIBUIDORA MEDICA PAREDES S.DE R · Mexico
$24.46
Top 5 dosage forms
1
Injection
$219K
2
Tablet
$3K
3
Other
$3K
4
Vial
$979.07
5
Unknown
$188.11
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 0 | $0.0000 | — |
| Nov | 8 | $148K | $19K |
| Dec | 11 | $77K | $7K |
Shipment register · 19 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — SUN PHARMACEUTICAL INDUSTRIES LTD · 6 shipments · $151K | |||||||||||
| 1 | Nov 2025 | SUN FARMACEUTICA DO BRASIL LTDA | Brazil | Injection | 3.0K | NOS | $3.16 | $10K | DELHI AIR | RIO DE JANEIRO - GAL | AIR |
| 2 | Nov 2025 | SUN FARMACEUTICA DO BRASIL LTDA | Brazil | Injection | 6.9K | NOS | $6.36 | $44K | DELHI AIR | RIO DE JANEIRO - GAL | AIR |
| 3 | Nov 2025 | SUN FARMACEUTICA DO BRASIL LTDA | Brazil | Injection | 3.8K | NOS | $4.16 | $16K | DELHI AIR | R JANIERO , RJ | AIR |
| 4 | Nov 2025 | UNKNOWN BUYER | Brazil | Injection | 3.8K | NOS | $4.16 | $16K | DELHI AIR | R JANIERO , RJ | AIR |
| 5 | Dec 2025 | SUN FARMACUTICA DO BRASIL LTDA | Brazil | Injection | 2.3K | NOS | $4.22 | $10K | DELHI AIR | R JANIERO , RJ | AIR |
| 6 | Dec 2025 | SUN FARMACEUTICA DO BRASIL LTDA | Brazil | Injection | 13.3K | NOS | $4.25 | $56K | DELHI AIR | RIO DE JANEIRO - GAL | AIR |
| SUPPLIER #2 — FRESENIUS KABI ONCOLOGY LTD · 2 shipments · $34K | |||||||||||
| 7 | Nov 2025 | FRESENIUS KABI CHILE LTDA | Chile | Injection | 2.0K | VLS | $16.63 | $33K | DELHI AIR | SANTIAGO DE CHILE - | AIR |
| 8 | Dec 2025 | BIO TECH PHARMA S.A | Costa Rica | Injection | 2.0K | VLS | $0.200 | $400.61 | DELHI AIR | SAN JOSE | AIR |
| SUPPLIER #3 — GETWELL PHARMA INDIA PVT LTD · 2 shipments · $30K | |||||||||||
| 9 | Nov 2025 | PZAC CORP | Dominican Republic | Injection | 500 | NOS | $29.94 | $15K | DELHI AIR | SANTO DOMINGO | AIR |
| 10 | Nov 2025 | UNKNOWN BUYER | Dominican Republic | Injection | 500 | NOS | $29.94 | $15K | DELHI AIR | SANTO DOMINGO | AIR |
| SUPPLIER #4 — MYGENIC HEALTHCARE PVT LTD · 3 shipments · $8K | |||||||||||
| 11 | Dec 2025 | UNLISTED BUYER | Mexico | Injection | 200 | NOS | $13.27 | $3K | MUMBAI AIR (SAHAR) | MEXICO CITY | AIR |
| 12 | Dec 2025 | UNLISTED BUYER | Mexico | Tablet | 200 | NOS | $13.27 | $3K | MUMBAI AIR (SAHAR) | MEXICO CITY | AIR |
| 13 | Dec 2025 | UNLISTED BUYER | Mexico | Other | 200 | NOS | $13.26 | $3K | MUMBAI AIR (SAHAR) | MEXICO CITY | AIR |
| SUPPLIER #5 — MSN LABORATORIES PVT LTD · 1 shipments · $2K | |||||||||||
| 14 | Dec 2025 | MSN LABS CHILE SPA | Chile | Injection | 300 | NOS | $6.46 | $2K | HYDERABAD ICD | VALPARAISO | ICD |
| SUPPLIER #6 — MEDINEX HEALTHCARE · 2 shipments · $979.07 | |||||||||||
| 15 | Dec 2025 | UNLISTED BUYER | Mexico | Vial | 30 | VLS | $19.38 | $581.32 | MUMBAI AIR (SAHAR) | MEXICO CITY | AIR |
| 16 | Dec 2025 | UNLISTED BUYER | Mexico | Vial | 30 | VLS | $13.26 | $397.74 | MUMBAI AIR (SAHAR) | MEXICO CITY | AIR |
| SUPPLIER #7 — P.K.EXPORTS · 1 shipments · $188.11 | |||||||||||
| 17 | Nov 2025 | DRYANELIS LEON | Saint Kitts and Nevis | 10 | PCS | $18.81 | $188.11 | DELHI AIR | ST KITTS | AIR | |
| SUPPLIER #8 — MILES INTERNATIONAL · 1 shipments · $82.68 | |||||||||||
| 18 | Dec 2025 | UNLISTED BUYER | Cayman Islands | Injection | 10 | VLS | $8.27 | $82.68 | MUMBAI AIR (SAHAR) | GRAND CAYMAN | AIR |
| SUPPLIER #9 — ATLAS ENTERPRISES · 1 shipments · $24.46 | |||||||||||
| 19 | Dec 2025 | DISTRIBUIDORA MEDICA PAREDES S.DE R | Mexico | Injection | 200 | NOS | $0.122 | $24.46 | MUMBAI AIR (SAHAR) | MEXICO CITY | AIR |
10
PART VI — DRILL-DOWN · OCEANIA
Region: Oceania
1 countries · 1 shipments · $449.02 · 1 Indian suppliers · 1 buyers
SHIPMENTS
1
USD
$449.02
COUNTRIES
1
SUPPLIERS
1
BUYERS
1
HHI
10,000
concentrated
Top 1 destination countries in Oceania
1
Papua New Guinea (100.0%)
$449.02
Top 1 Indian suppliers into Oceania
1
BRUCK PHARMA PVT LTD
$449.02
Top 0 Oceania importers
Top 1 dosage forms
1
Injection
$449.02
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 0 | $0.0000 | — |
| Nov | 0 | $0.0000 | — |
| Dec | 1 | $449.02 | $449.02 |
Shipment register · 1 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — BRUCK PHARMA PVT LTD · 1 shipments · $449.02 | |||||||||||
| 1 | Dec 2025 | UNLISTED BUYER | Papua New Guinea | Injection | 50 | NOS | $8.98 | $449.02 | MUMBAI AIR (SAHAR) | PORT MORESBY | AIR |
10
PART VI — EVIDENCE REGISTER
Indian Supplier Directory
All 41 Indian bortezomib exporters — complete list ranked by USD
KEY TAKEAWAY
This directory lists every Indian company that shipped bortezomib in 2025-Q4.
S FOR SUPPLIERS
Find yourself and your competitors. Compare shipment count, USD, and destination regions.
B FOR BUYERS
Search for potential Indian suppliers. Filter by dosage form and destination region.
| # | Supplier | City | Ships | USD | Dosage forms | Primary regions |
|---|---|---|---|---|---|---|
| 1 | SUN PHARMACEUTICAL INDUSTRIES LTD | MUMBAI | 11 | $674K | Injection | Europe, Americas |
| 2 | MSN LABORATORIES PVT LTD | HYDERABAD | 3 | $133K | Vial, Injection | Asia, Americas |
| 3 | FRESENIUS KABI ONCOLOGY LTD | NEW DELHI | 7 | $77K | Injection | Europe, Americas |
| 4 | MYLAN LABORATORIES LTD | BANGALORE | 1 | $73K | Injection | Asia |
| 5 | GETWELL PHARMA INDIA PVT LTD | GURGAON | 5 | $35K | Injection | Africa, Americas |
| 6 | SAMARTH LIFE SCIENCES PVT LTD | NALAGARH | 2 | $21K | Injection | Asia |
| 7 | BRUCK PHARMA PVT LTD | NANI | 4 | $15K | Injection | Africa, Asia |
| 8 | GLENMARK PHARMACEUTICALS LTD | SOLAN | 1 | $11K | Injection | Africa |
| 9 | THERDOSE PHARMA PVT LTD | PRAGATHI NAGAR | 1 | $8K | Injection | Asia |
| 10 | MYGENIC HEALTHCARE PVT LTD | NAVI MUMBAI | 3 | $8K | Injection, Tablet, Other | Americas |
| 11 | ARECHAR HEALTHCARE LLP | New delhi | 1 | $6K | Injection | Africa |
| 12 | KWALITY PHARMACEUTICALS LTD | AMRITSAR | 1 | $5K | Injection | Asia |
| 13 | KERK | DELHI | 3 | $4K | Injection | Asia |
| 14 | R.S. SURGIPHARM PVT LTD | AHMEDABAD | 4 | $3K | Injection | Africa |
| 15 | SANSKRUTI PHARMA | SURAT | 5 | $3K | Injection | Africa |
| 16 | BIOZENTA LIFESCIENCE PVT LTD | Una | 2 | $2K | Injection | Africa |
| 17 | ADLEY FORMULATIONS PVT LTD | BADDI | 1 | $2K | Injection | Asia |
| 18 | J S LABS | HYDERABAD | 5 | $2K | Europe | |
| 19 | RESCUERS LIFE SCIENCES LTD | NALAGARH ROAD BADDI | 1 | $2K | Injection | Asia |
| 20 | GALAXY SUPER SPECIALITY | NEW DELHI | 1 | $1K | Injection | Asia |
| 21 | MEDINEX HEALTHCARE | Mumbai | 2 | $979.07 | Vial | Americas |
| 22 | J.A. UNITED EXPORTS PVT LTD | VASHI | 3 | $757.35 | Injection | Asia |
| 23 | OCEAN PHARMACEUTICAL | VADODARA | 1 | $739.48 | Injection | Asia |
| 24 | VATS INDUSTRIES PVT LTD | NEW DELHI | 2 | $701.59 | Injection | Asia |
| 25 | SAYAR LIFE-CARE | Chennai | 1 | $582.39 | Vial | Africa |
| 26 | MATOSHREE HEALTH CARE PVT LTD | THAKURDWAR MUMBAI | 1 | $307.23 | Injection | Africa |
| 27 | M T MADON EXPORTS | MUMBAI | 2 | $306.31 | Injection | Africa |
| 28 | MEDMATRIX ASSOCIATES | AMBALA | 1 | $306.15 | Injection | Asia |
| 29 | RUN MEDWAY | SURAT | 1 | $244.78 | Injection | Africa |
| 30 | VENUS REMEDIES LTD | Behra | 1 | $240.18 | Powder | Africa |
| 31 | SEATRACK INTERNATIONAL TRADEX PVT LTD | NEW DELHI | 1 | $207.17 | Injection | Asia |
| 32 | RMPL PHARMA LLP | MUMBAI | 2 | $195.49 | Injection | Asia |
| 33 | P.K.EXPORTS | AJMER | 1 | $188.11 | Americas | |
| 34 | MILES INTERNATIONAL | MUMBAI | 1 | $82.68 | Injection | Americas |
| 35 | MEDICOS LIFESCIENCES | AHMEDABAD | 1 | $79.57 | Injection | Africa |
| 36 | HUMANKIND PHARMA | Mumbai | 1 | $63.98 | Injection | Asia |
| 37 | SARTAJ PHARMA PVT LTD | CHANDNI CHOWK | 1 | $31.32 | Injection | Asia |
| 38 | ATLAS ENTERPRISES | NAGPUR | 1 | $24.46 | Injection | Americas |
| 39 | GENETEC LIFESCIENCES | MUMBAI | 1 | $3.87 | Africa | |
| 40 | GRAMEEN PHARMA LLP | Mumbai | 1 | $2.94 | Injection | Africa |
| 41 | YOGI CARE PHARMACEUTICAL PVT LTD | AHMEDABAD | 1 | $1.72 | Injection | Africa |
10
PART VI — EVIDENCE REGISTER
Global Buyer Directory
All 34 global bortezomib importers — complete list ranked by USD
KEY TAKEAWAY
This directory lists every company that imported Indian bortezomib in 2025-Q4.
S FOR SUPPLIERS
Search for potential customers by country and dosage form.
B FOR BUYERS
Find your company and see which Indian supplier serves you.
| # | Buyer | Country | Ships | USD | Primary supplier | Dosage forms |
|---|---|---|---|---|---|---|
| 1 | YUSEN LOGISTICS BENELUX BELGIUM | Belgium | 3 | $275K | SUN PHARMACEUTICAL I… | Injection |
| 2 | MEDIHOME LTD | Israel | 2 | $131K | MSN LABORATORIES PVT… | Vial |
| 3 | SUN FARMACEUTICA DO BRASIL LTDA | Brazil | 4 | $126K | SUN PHARMACEUTICAL I… | Injection |
| 4 | VIATRIS PHARMACEUTICALS (THAILAND) | Thailand | 1 | $73K | MYLAN LABORATORIES LTD | Injection |
| 5 | FRESENIUS KABI DEUTSCHLAND GMBH | Germany | 3 | $41K | FRESENIUS KABI ONCOL… | Injection |
| 6 | FRESENIUS KABI CHILE LTDA | Chile | 1 | $33K | FRESENIUS KABI ONCOL… | Injection |
| 7 | TRUST ANESTHETIC LTD | Afghanistan | 2 | $16K | SAMARTH LIFE SCIENCE… | Injection |
| 8 | PZAC CORP | Dominican Republic | 1 | $15K | GETWELL PHARMA INDIA… | Injection |
| 9 | GLENMARK PHARMACEUTICALS SOUTH | South Africa | 1 | $11K | GLENMARK PHARMACEUTI… | Injection |
| 10 | SUN FARMACUTICA DO BRASIL LTDA | Brazil | 1 | $10K | SUN PHARMACEUTICAL I… | Injection |
| 11 | ESSENCE LIFE | Lebanon | 1 | $8K | THERDOSE PHARMA PVT … | Injection |
| 12 | MEDICAL STORES DEPARTMENT | Tanzania | 1 | $6K | ARECHAR HEALTHCARE LLP | Injection |
| 13 | MUBARAK HASHIMI LTD | Afghanistan | 3 | $4K | KERK | Injection |
| 14 | CENTRALE DACHATS DE MEDICAMENTS | Madagascar | 2 | $3K | GETWELL PHARMA INDIA… | Injection |
| 15 | SIJAL PHARMA PVT LTD | Nepal | 1 | $2K | ADLEY FORMULATIONS P… | Injection |
| 16 | NAIROBI ENTERPRISES LTD | Kenya | 1 | $2K | GETWELL PHARMA INDIA… | Injection |
| 17 | JSC RAFARMA | Russia | 5 | $2K | J S LABS | |
| 18 | MSN LABS CHILE SPA | Chile | 1 | $2K | MSN LABORATORIES PVT… | Injection |
| 19 | ETEMED MOSLEH LTD | Afghanistan | 1 | $2K | RESCUERS LIFE SCIENC… | Injection |
| 20 | EUROFINS BIOPHARMA PRODUCT TESTING | Hungary | 1 | $1K | FRESENIUS KABI ONCOL… | Injection |
| 21 | AL-NOOR FOR DRUGS & MEDICAL APPLIAN | Yemen | 3 | $757.35 | J.A. UNITED EXPORTS … | Injection |
| 22 | ANSYNC GLOBAL FZCO | United Arab Emirates | 1 | $739.48 | OCEAN PHARMACEUTICAL | Injection |
| 23 | ATLAS TRADING COMPANY | Iraq | 2 | $701.59 | VATS INDUSTRIES PVT … | Injection |
| 24 | MINISTRY OF HEALTH ( CLAUDE JULIEN | Seychelles | 1 | $582.39 | SAYAR LIFE-CARE | Vial |
| 25 | BIO TECH PHARMA S.A | Costa Rica | 1 | $400.61 | FRESENIUS KABI ONCOL… | Injection |
| 26 | SALAMA PHARMACUTICALS LTD | Kenya | 2 | $306.31 | M T MADON EXPORTS | Injection |
| 27 | GULF IMPEX FZC | Afghanistan | 1 | $306.15 | MEDMATRIX ASSOCIATES | Injection |
| 28 | ZMC EXPRESS CARGO FZCO | United Arab Emirates | 2 | $271.16 | SEATRACK INTERNATION… | Injection |
| 29 | CLYZ PHARMA SARL | Cameroon | 1 | $244.78 | RUN MEDWAY | Injection |
| 30 | DRYANELIS LEON | Saint Kitts and Nevis | 1 | $188.11 | P.K.EXPORTS | |
| 31 | LUSAKA PHARMA CHEM SUPPLIES LTD | Zambia | 1 | $79.57 | MEDICOS LIFESCIENCES | Injection |
| 32 | SARTAJ ENTERPRISES LTD | Afghanistan | 1 | $31.32 | SARTAJ PHARMA PVT LTD | Injection |
| 33 | DISTRIBUIDORA MEDICA PAREDES S.DE R | Mexico | 1 | $24.46 | ATLAS ENTERPRISES | Injection |
| 34 | THE MANAGER SA | Ghana | 1 | $2.94 | GRAMEEN PHARMA LLP | Injection |
This report covers 89 2025-Q4 Bortezomib shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/bortezomib
Talk to our trade analyst
Need a custom bortezomib report or a deeper dive into any market? Our team is ready.
WhatsApp: +91 95950 78788 · transdatanexus.com
PHARMA TRADE INTELLIGENCE
Thank you for reading
This report is part of the TransData Nexus Pharma Trade Intelligence series, covering 366 pharmaceutical products exported from India.
Every figure is grounded in real commercial trade records — official customs filings and licensed databases. No surveys, no estimates, no fake data.
Need a custom report?
We can generate intelligence for any pharmaceutical product, any time period, any combination of source and destination countries.
Want deeper analysis?
Our team provides competitive intelligence, market entry strategy, and supply chain due diligence for pharma importers and exporters.
Scan for product page
WhatsApp: +91 95950 78788
Email: info@transdatanexus.com
Web: https://transdatanexus.com/pharmaceutical/bortezomib
© 2026 TransData Nexus. All rights reserved. This report is provided for informational purposes only.
Data sourced from official customs filings and licensed commercial trade databases.
Reproduction without permission is prohibited.
Explore the full Bortezomib product page
Live data, supplier directory, price trends, and trade route analysis